Events & Presentations
Stifel Nicolaus Healthcare Conference
Boston, MA
September 15-17, 2010
Speaker: Dr. Rahul Singhvi
Webcast
4th Vaccine and ISV Annual Global Congress
Vienna, Austria
October 3-5, 2010
RSV F-Micelle Vaccine Induced a Robust Neutralizing Antibody Response and Completely Protected Mice Following RSV Challenge;
Safety & Immunogenicity of a Seasonal Influenza VLP Vaccine in Healthy, Older Adults and;
Immunogenicity in Mice Induced by a Novel Particulate Varicella Zoster Vaccine Candidate
Presenters: Drs. Rama Raghunandan and Kevin Connolly
9th Annual BIO Investor Forum
San Francisco, CA
October 5-6, 2010
Speaker: Frederick Driscoll
New Cells, New Vaccines V: Global Perspectives
Wilmington, DE
October 10-13, 2010
New Technologies: Biological Efficacy in Vaccine Applications
Broad Immune Response to Virus-like Particle (VLP) Vaccines in Clinical Trials and;
Development and Preclinical Promise of a New F-Micelle RSV Vaccine
Speakers: Drs. Steven Pincus and Rama Raghunandan
IDSA 48th Annual Meeting
Vancouver, Canada
October 21-24, 2010
A Broad Immune Response to Seasonal Influenza VLP Vaccine in Healthy Adults and;
Immunization of Healthy Adults with H5N1 Influenza VLP Vaccine Induced Cell Mediated and Humoral Immunity Including Functional Antibodies Against Neuraminidase
Presenters: Drs. Kevin Connolly and Steven Pincus
IBC’s 14th Annual Well-Characterized Biologicals
Bethesda, MD
October 22, 2010
Case Study: Biophysical and Biochemical Characterization of Insect Cell Produced VLP Vaccines
Speaker: Dr. Steven Pincus
Keystone Symposia; Immunological Mechanisms of Vaccination
Seattle, WA
October 27-November 1, 2010
Neuraminidase (NA) Antibodies Play a Complex Role in the Immunogenicity Induced by Virus-like Particle (VLP) Influenza Vaccines and;
Rapid Response to the 2009 H1N1 Influenza Pandemic in Mexico—Safety and Immunogenicity Results in a Phase 2 Clinical Trial Using an H1N1 Virus-like Particle (VLP) Vaccine
Presenter: Dr. Rama Raghunandan
8th Annual Vaccines: All Things Considered Conference
Washington, DC
November 8-9, 2010
Speaker: Dr. Rahul Singhvi
2010 Influenza Congress USA
Washington, DC
November 8-10, 2010
Case Study: Facilitate Entrance to the U.S. Market through Foreign Market
Speaker: Dr. Rahul Singhvi
Panel Session: Identifying the Optimal Business Model for Your Biotech
Speaker: John Trizzino